Pfizer buries data showing mRNA flu vaccine bombed in trial with elderly, not much better under 65
More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual filing cabinet" and touts absolute difference of 0.32% for non-elderly adults in prestigious journal.
No comments:
Post a Comment